| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OTRA | Class A Common Stock | Conversion of derivative security | +1,305,918 | 1,305,918 | 20 May 2022 | Direct | F1, F2 | |||
| transaction | OTRA | Class A Common Stock | Other | -1,305,918 | -100% | 0 | 20 May 2022 | Direct | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OTRA | Class B Common Stock | Conversion of derivative security | $0 | -1,305,918 | -100% | $0.000000* | 0 | 20 May 2022 | Class A Common Stock | 1,305,918 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | As described in the OTR Acquisition Corp.'s registration statement on Form S-1 (File No. 333-248093) under the heading "Description of Securities," the Class B common stock of the issuer automatically converts into Class A common stock of the issuer ("Class A Common Stock") at the time of the issuer's initial business combination or earlier at the option of the holders thereof, on a one-for-one basis, subject to certain adjustments described therein, and have no expiration date. |
| F2 | (Continued from Footnote 1) On May 20, 2022, the issuer consummated its initial business combination (the "Business Combination") with Comera Life Sciences Holdings, Inc.. ("Holdco"), a Delaware corporation. In connection with the Business Combination, each share of Class B Common Stock converted into Class A Common Stock. |
| F3 | In connection with the Business Combination, the reporting person exchanged its shares of Class A Common Stock for 1,305,918 fully paid and non-assessable shares of common stock, par value U.S. $0.0001 per share, of Holdco. |